Healthcare Global Enterprises Ltd reports Q1 FY27 revenue up 13%, EBITDA up 20%
Healthcare Global Enterprises · Healthcare Services
Key highlights
- Q1 FY27 revenue: ₹695.1 crore, up 13% YoY; adjusted EBITDA: ₹133.9 crore, up 20% YoY with 19.4% margin
- Opened 120+ bed North Bangalore hospital in May 2026; added 121 beds across network including Ranchi, Borivali, Nashik
- International business revenue ₹20.8 crore, up 9% YoY; fertility business divested in June 2026 with ₹16.9 crore revenue in Q1 FY27
Why it's rated major development: the year-on-year change is 190% (50% or more)
Figures checked against the filing by a second AI read. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Healthcare Global Enterprises
- Financial resultsMajor development· Adverse for the businessHealthCare Global Enterprises approves audited FY2025-26 results and BACC divestment
Other capex / expansion filings this fortnight
- Maharaja & Speedex India Limited raises manufacturing capacity to 72 lakh units/year
- Elin Electronics Q2 FY27 earnings report with 10% revenue growth and margin update
- HOAC Foods India Limited H1 FY27 Earnings Call Transcript dated November 5, 2026
- Gujarat State Fertilizers & Chemicals Limited Q2 FY27 Earnings Call Highlights
- Supriya Lifescience H1 revenue up 14.8% to ₹396.04 crore; Q2 profit falls
- V-MARC India Ltd announces Q2 & H1 FY27 unaudited financial results and review report
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM QualityGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.